QGEN

QGEN

USD

Qiagen N.V. Common Shares

$44.160-1.160 (-2.560%)

Цена в режиме реального времени

Healthcare
Diagnostics & Research
Нидерланды

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$45.320

Максимум

$47.355

Минимум

$43.260

Объем

0.66M

Фундаментальные показатели компании

Рыночная капитализация

9.6B

Отрасль

Diagnostics & Research

Страна

Netherlands

Статистические данные торговли

Средний объем

1.21M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $37.63Текущая $44.160Максимум $51.88

Связанные новости

BusinessWire

QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025

QIAsymphony Connect, the next generation of automated nucleic acid purification platform, to be shown at AMP 2025 as early access phase begins ahead of full release in mid-2026 QIAGEN showcases Sample to Insight

Просмотреть больше
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025
BusinessWire

QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions

Parse Biosciences is a fast-growing innovator in single-cell sample preparation, with technologies used in more than 3,000 labs across over 40 countries Acquisition strengthens QIAGEN's presence in the rapidly

Просмотреть больше
QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions
BusinessWire

QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase

Q3 2025 results: Net sales of $533 million (+6% at actual rates); diluted EPS $0.60 Core sales +6% CER (constant exchange rates) driven by QIAstat-Dx (+11% CER), QuantiFERON (+11% CER) and Sample technologies (+3%

Просмотреть больше
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase
BusinessWire

QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025

New EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNA Workflow on EZ2 Connect Fx delivers high-quality DNA in under 2.5

Просмотреть больше
QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025
BusinessWire

QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing

QIAcube Connect drives lab efficiency by automating critical steps in molecular biology workflows for both research and clinical customers Milestone builds on nearly 13,000 cumulative placements of QIAcube family

Просмотреть больше
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.